EE604 Cost-Effectiveness Analysis of Single-Inhaler Triple Therapy (FF/UMEC/VI) in COPD Using the Impact Trial: China Medical Insurance System Perspective
Abstract
Authors
X. Wang A. Martin R. Cai Z. Tang D. Bointon S.G. Noorduyn A. Sun A. Ismaila